PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Approaches for optimal use of different COVID-19 vaccines

2021-03-04
(Press-News.org) What The Article Says: This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson & Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination and single mRNA immunization of people with prior documented SARS-CoV-2 infection.

Authors: John P. Moore, Ph.D., of Weill Cornell Medicine in New York, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2021.3465)

Editor's Note: The article includes an Editor's Note. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

INFORMATION:

Media advisory: The full article is linked to this news release. A livestream with the author also is scheduled for Thursday at 3:50 P.M. (ET) and will be available here: http://ja.ma/moore0304

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3465?guestAccessKey=a44d6501-b605-47f2-970e-f8cc12936363&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030421



ELSE PRESS RELEASES FROM THIS DATE:

Antisense oligonucleotides as a feasible therapy to treat MECP2 dupli

2021-03-04
Many cognitive neurodevelopmental disorders are a result of too many or too few copies of certain genes or chromosomes. To date, no treatment options exist for this class of disorders. MECP2 duplication syndrome (MDS) is one such disorder that primarily affects boys and results from a duplication spanning the methyl-CpG binding protein 2 (MECP2) locus located on the X chromosome. A preclinical study published from the laboratory of Dr. Huda Zoghbi, professor at Baylor College of Medicine and director of the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, provides experimental evidence that supports the use of antisense oligonucleotides as ...

Artificial intelligence reveals current drugs that may help combat Alzheimer's disease

2021-03-04
BOSTON - New treatments for Alzheimer's disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options. Now a team at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) has developed an artificial intelligence-based method to screen currently available medications as possible treatments for Alzheimer's disease. The method could represent a rapid and inexpensive way to repurpose existing therapies into new treatments for this progressive, debilitating neurodegenerative condition. ...

Newly discovered millipede, Nannaria hokie, lives at Virginia Tech

Newly discovered millipede, Nannaria hokie, lives at Virginia Tech
2021-03-04
Hearing the words "new species discovered" may conjure images of deep caves, uncharted rainforests, or hidden oases in the desert. But the reality is that thousands of new species are discovered each year by enterprising scientists all over the world. Many of these new species do come from exotic locations, but more surprisingly, many come from just down the road, including the newest member of the Hokie Nation, the millipede Nannaria hokie. The newest Hokie -- which has about 60 more legs than the HokieBird ­-- was discovered living under rocks by the Duck Pond behind the Grove on Virginia Tech's Blacksburg campus. Since then, the critter has been found at the area commonly referred to as stadium ...

New evidence COVID-19 antibodies, vaccines less effective against variants

New evidence COVID-19 antibodies, vaccines less effective against variants
2021-03-04
New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to vaccination or natural infection, or were purified antibodies intended for use as drugs, the researchers found more antibody is needed to neutralize the new variants. The findings, from laboratory-based experiments and published March 4 in Nature Medicine, suggest that COVID-19 drugs and vaccines developed thus far may become less effective ...

Smoking cessation drug may treat Parkinson's in women

2021-03-04
Texas A&M University College of Medicine ressearchers have recently discovered that cytisine -- a smoking cessation drug commonly used in Europe -- reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson's disease or stop its progression in women. Sara Zarate and Gauri Pandey, graduate students from the lab of Rahul Srinivasan, assistant professor in the Department of Neuroscience & Experimental Therapeutics, are co-first authors of the research. Their findings are published in the Journal of Neurochemistry. There ...

Key enzymes for synthesizing natural products

2021-03-04
Plants, fungi, and bacteria produce natural products that function, among other things, as defenses that are deployed against predators and competitors. In medicine, these compounds are used for antibiotics, cancer drugs, and cholesterol reducers. The team working with associate professor Dr. Robin Teufel and Dr. Britta Frensch of the Institute of Biology II of the Faculty of Biology of the University of Freiburg was able, together with researchers from the ETH Zürich in Switzerland, to shed light on the key role of three enzymes that are involved in synthesizing a class of natural products. The researchers are publishing their findings in the latest edition of "Nature Communications." Actinobacteria produce many natural products, such as those that are ...

Will climate change outpace species adaptation?

2021-03-04
Many species might be left vulnerable in the face of climate change, unable to adapt their physiologies to respond to rapid global warming. According to a team of international researchers, species evolve heat tolerance more slowly than cold tolerance, and the level of heat they can adapt to has limits. In a study published in the Nature Communications, McGill professor Jennifer Sunday and her co-authors wanted to understand how species' thermal limits have evolved. To examine variation across the tree of life, the researchers developed the largest available database compiling thermal tolerances for all types of organisms (GlobTherm database). The ...

COVID-19 nasal swab test may not be best for those who've had sinus surgery

2021-03-04
SAN ANTONIO, March 4, 2021 -- People who have had major sinus surgery should consult their ENT doctor before undergoing COVID-19 swab testing, new research indicates. Likewise, those performing swab testing should ask whether the patient has had extensive sinus or skull base surgery, said END ...

Breaking the patrisharky: Scientists reexamine gender biases in shark, ray mating research

Breaking the patrisharky: Scientists reexamine gender biases in shark, ray mating research
2021-03-04
Shark scientists at Georgia Aquarium, Scripps Institution of Oceanography at UC San Diego, and Dalhousie University are challenging the status quo in shark and ray mating research in a new study that looks at biological drivers of multiple paternity in these animals. The results were published March 4 in the journal Molecular Ecology. Many species of sharks and rays exhibit multiple paternity, where females give birth to a litter of pups that have different fathers. While widely documented in scientific literature, the drivers of this phenomenon are not well understood. However, previous research has cited male aggression as ...

In professional athletes, heart risk after mild COVID-19 is very low, finds study

2021-03-04
NEW YORK, NY (March 4, 2021)--Inflammatory heart disease is a rare finding among professional athletes with mild or asymptomatic COVID-19 infection, a large-scale study has found. The study, led by Columbia University Vagelos College of Physicians and Surgeons in collaboration with the major North American sports leagues and their respective players' associations, was published online today in JAMA Cardiology. Athletes and COVID-19 Studies suggest that approximately 20% of patients hospitalized with severe COVID-19 develop some type of heart damage, but the impact of mild or asymptomatic ...

LAST 30 PRESS RELEASES:

New strategies to enhance chiral optical signals unveiled

Cambridge research uncovers powerful virtual reality treatment for speech anxiety

2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

[Press-News.org] Approaches for optimal use of different COVID-19 vaccines